Text Size
159 studies found for:    Esophagitis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis
Conditions: Esophagitis;   Reflux Esophagitis;   Gastroesophageal Reflux Disease
Intervention: Other: Cessation of Acid Suppressing Medications
2 Completed Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
Conditions: Erosive Esophagitis;   Reflux Esophagitis;   GERD
Intervention:
3 Recruiting Eosinophilic Esophagitis Databank
Conditions: Esophagitis;   Eosinophilic Esophagitis
Intervention:
4 Completed
Has Results 		Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis
Conditions: Esophagitis, Reflux;   Esophagitis, Peptic
Interventions: Drug: Dexlansoprazole MR;   Drug: Placebo
5 Completed
Has Results 		Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
Conditions: Esophagitis, Reflux;   Esophagitis, Peptic
Interventions: Drug: Dexlansoprazole MR;   Drug: Lansoprazole
6 Completed
Has Results 		Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis
Conditions: Esophagitis, Reflux;   Esophagitis, Peptic
Interventions: Drug: Dexlansoprazole MR;   Drug: Lansoprazole
7 Completed
Has Results 		Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis
Conditions: Esophagitis, Reflux;   Esophagitis, Peptic
Interventions: Drug: Dexlansoprazole MR;   Drug: Placebo
8 Completed
Has Results 		Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis
Conditions: Esophagitis, Reflux;   Esophagitis, Peptic
Interventions: Drug: Dexlansoprazole MR;   Drug: Placebo
9 Completed Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
Conditions: Eosinophilic;   Esophagitis;   Oesophagitis, Eosinophilic
Intervention: Drug: mepolizumab
10 Completed NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
Conditions: Erosive Esophagitis;   Reflux Esophagitis;   Gastroesophageal Reflux Disease
Intervention: Drug: esomeprazole magnesium (oral medication)
11 Completed An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients
Conditions: Oesophagitis, Eosinophilic;   Eosinophilic Oesophagitis in Adult Patients
Intervention: Drug: mepolizumab
12 Recruiting Nexium Capsules RE Maintenance Specific Clinical Experience Investigation
Conditions: Repeatedly Recurring Esophagitis;   Relapsing Reflux Esophagitis
Intervention:
13 Completed A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis
Condition: Erosive Esophagitis
Interventions: Drug: Esomeprazole;   Drug: Lansoprazole
14 Completed Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
Condition: Esophagitis
Interventions: Drug: esomeprazole;   Drug: fluticasone
15 Completed Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis
Condition: Esophagitis
Intervention: Drug: Infliximab
16 Completed Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: QAX576 placebo;   Drug: QAX576
17 Completed Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia
Condition: Esophagitis
Intervention: Procedure: EGD with biopsies
18 Completed A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
Condition: Esophagitis
Interventions: Drug: omalizumab;   Drug: Placebo
19 Completed
Has Results 		Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study
Condition: Erosive Esophagitis
Intervention: Drug: Omeprazole/sodium bicarbonate
20 Completed Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Condition: Eosinophilic Esophagitis
Intervention: Biological: Omalizumab
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years